Skip to main content
. 2023 Feb 20;11(2):e005701. doi: 10.1136/jitc-2022-005701

Figure 2.

Figure 2

Treatment-emergent adverse events. ALT, aminotransferase; CRS, cytokine release syndrome; Cr, creatinine; GVHD, graft-versus-host disease.